Skip to content

Lifevantage Corporation LFVN Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

USANA Health Sciences logo
USANA Health SciencesUSNA
NuSkin Enterprises logo
NuSkin EnterprisesNUS
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
The Beauty Health Company logo
The Beauty Health CompanySKIN
NAG
Niagen Bioscience, Inc. Common StockNAGE
Solesence, Inc. Common Stock logo
Solesence, Inc. Common StockSLSN

Other financials

Income statement

See full
Revenue$43.7M-25.2%
Gross profit$34.5M-27.0%
Operating income$1.7M-58.6%
Net income$1.4M-60.7%
EPS (diluted)$0.11-57.7%

Balance sheet

See full
Cash & equivalents$12.5M-44.4%
Total debt$10.2M-17.4%
Total equity$33.3M-2.0%
Total assets$62.1M-19.6%

Cash flow

See full
Operating cash flow$5.0M+124%
CapEx$1.0M+205%
Free cash flow$4.0M+110%

Valuation

See full
Market cap$78.72M-51.4%
Enterprise value$76.45M-50.2%
P/E13.7×-2.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin78.1%-2.2pp
Operating margin3.4%-2.5pp
Net margin2.9%-1.2pp
FCF margin3.8%+1.1pp

Returns & leverage

See full
Return on equity17.1%-13.0pp
Debt / equity0.3×-0.1×
Current ratio+0.3×

Where this comes from

Reported directly by Lifevantage Corporation in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Lifevantage Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifevantage Corporation's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifevantage Corporation's common stock, shares authorized (in shares)?
Lifevantage Corporation (LFVN) reported common stock, shares authorized (in shares) of $40M in Q1 2026.
How has Lifevantage Corporation's common stock, shares authorized (in shares) changed year-over-year?
Lifevantage Corporation's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $40M to $40M.
What is the long-term trend for Lifevantage Corporation's common stock, shares authorized (in shares)?
Over 4 years (2021 to 2025), Lifevantage Corporation's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $40M to $40M.